Home
About Us
Corporate Profile
Milestones
Board Of Directors
Executive Team
Group Policies
Business Segments
Investor Relations
Financial Highlights
SGX Announcements
News
Event Calendar
Annual Report & Other Reports
Email Alert
Contact
Scam Alert
Home
News
News
News
By Year:
All
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
2018
25 Mar 2024
Change of Director’s Interest – Chan Kiat
22 Mar 2024
Change of Director’s Interest – Dr Tan Kia King
13 Mar 2024
CGS International Equity Research: FY2023 Positive on Expanding Portfolio
12 Mar 2024
General Announcement: Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics
06 Mar 2024
FY2023 Full-Year Financial Results Briefing
29 Feb 2024
General Announcement: Hyphens Pharma’s Ceradan range of products to enter major Middle East markets
27 Feb 2024
Financial Statements and Related Announcement: Full Yearly Results
06 Feb 2024
General Announcement: Hyphens Pharma partners 7-Eleven to offer Ocean Health® supplements at selected convenience stores in Singapore
08 Dec 2023
Employee Stock Option/Share Scheme: Grant of Share Awards Pursuant to the Hyphens Share Plan
27 Nov 2023
CGS-CIMB Equity Research: Dented Margins in 3Q23
20 Nov 2023
SAC Equity’s Capital Research – 3Q23 Business Update
09 Nov 2023
The Edge Singapore: Hyphens Pharma’s high returns to shareholders fuelled by a post-pandemic boom, accretive acquisition
09 Nov 2023
General Announcement: Quarterly Business Update for the Third Quarter and Nine Months Ended 30 September 2023
08 Nov 2023
Asset Acquisitions and Disposals: Completion Of Proposed Acquisition Of Tranche 1 Sale Shares Of 23% In Ardence Pharma Sdn Bhd
20 Oct 2023
SAC Equity’s Capital Research – Pursuing Growth Through Full Acquisition of Ardence Pharma
19 Oct 2023
General Announcement : Analyst Briefing – Acquisition of Ardence Malaysia
17 Oct 2023
Asset Acquisitions and Disposals: Proposed Acquisition Of 58% Of The Share Capital In Ardence Pharma Sdn Bhd Over 3 Tranches
17 Oct 2023
The Edge Singapore: Hyphens Pharma to acquire remaining 58% of shares in Ardence Pharma, making it a wholly-owned subsidiary
30 Aug 2023
General Announcement: Nabota® successfully registered in Malaysia
22 Aug 2023
PhillipCapital’s Equity Research – Year of Investment and Challenges
18 Aug 2023
Investor-One: What You Need to Know About Hyphens Pharma’s 1H2023 Financial Results
18 Aug 2023
CGS-CIMB Equity Research: A Game of Catch-Up for 2H23F
17 Aug 2023
SAC Equity’s Capital Research – Navigating Challenges Amidst Ongoing Improvements
17 Aug 2023
General Announcement: Results Briefing 1H 2023
11 Aug 2023
Financial Statements and Related Announcement: Half Yearly Results
11 Aug 2023
Cash Dividend / Distribution: Mandatory
19 Jul 2023
Change of Substantial Shareholder’s Interest – Inomed Holding Pte Ltd
19 Jul 2023
Change of Director’s Interest – Mr Lim See Wah
19 Jul 2023
Change of Director’s Interest – Dr Tan Kia King
19 Jul 2023
Cessation of Substantial Shareholder’s Interest – Mr Tan Chwee Choon
05 Jun 2023
(Board Approval) Hyphens Pharma International – Appointment of CFO
25 May 2023
SAC Capital’s Equity Research – Beyond the Shores
24 May 2023
General Announcement: Minutes of Annual General Meeting and Extraordinary General Meeting held on 26 April 2023
17 May 2023
General Announcement: Hyphens Pharma to develop and commercialise Byfavo procedural sedation drug in Singapore
16 May 2023
CGS-CIMB Singapore’s Equity Research – Hit by Supply Chain Disruptions
11 May 2023
General Announcement: Business Update and Results Briefing for the First Quarter Ended 31 March 2023
28 Apr 2023
Employee Stock Option / Share Scheme: Allotment and Issuance of 422,000 New Ordinary Shares Under the Hyphens Performance Share Plan
26 Apr 2023
Results of Extraordinary General Meeting held on 26 April 2023
26 Apr 2023
Results of Annual General Meeting held on 26 April 2023
21 Apr 2023
Response to Queries from SIAS on Annual Report 2022
21 Apr 2023
Response to Substantial and Relevant Questions Received from Shareholders before Annual General Meeting
13 Apr 2023
CGS-CIMB Singapore’s Equity Research – DocMed Undertakes Vietnam Digital Venture
10 Apr 2023
Announcement of Cessation: Cessation of an Executive Director
10 Apr 2023
Cash Dividend / Distribution: Mandatory
10 Apr 2023
Notice of Extraordinary General Meeting
10 Apr 2023
Notice of Annual General Meeting
10 Apr 2023
Annual Report 2022
10 Apr 2023
Annual Reports and Related Documents
09 Mar 2023
PhillipCapital’s Equity Research – Assembling Multiple Growth Engines
07 Mar 2023
CGS-CIMB Singapore’s Equity Research – FY23F Sets Stage for More Investments
06 Mar 2023
General Announcement: Results Briefing FY2022
28 Feb 2023
Financial Statements and Related Announcement: Full Yearly Results
10 Feb 2023
General Announcement: Nabota® Successfully Registered in Singapore
30 Jan 2023
The Business Times – Hyphens Pharma to expand footprint in Southeast Asia: CEO
21 Dec 2022
General Announcement: Hyphens Pharma licenses Winlevi® for all 10 ASEAN countries from Cosmo Pharmaceuticals
05 Dec 2022
General Announcement: Hyphens Pharma’s Meradan® Cream Launches in Indonesia
24 Nov 2022
CGS-CIMB Singapore’s Equity Research – Steadfast in Executing its Business Strategy
09 Nov 2022
General Announcement: Quarterly Business Update for the Third Quarter and Nine Months Ended 30 September 2022
15 Sep 2022
General Announcement: Hyphens Pharma’s TDF Blu Voile Sunscreen
28 Aug 2022
PhillipCapital’s Equity Research – Franchise Expands with Acquisitions
25 Aug 2022
联合早报 – 善用传统学养与数码能力首创综合式医疗科技平台
18 Aug 2022
SAC Capital’s Equity Research – Growth from Organic and Acquisition
17 Aug 2022
CGS-CIMB Singapore’s Equity Research – Positioning for Next Phase of Growth
17 Aug 2022
General Announcement: Results Briefing 1H2022
11 Aug 2022
Financial Statements and Related Announcement: Half Yearly Results
06 Jun 2022
General Announcement: Completion of Investment in DocMed Technology
06 Jun 2022
SAC Capital’s Equity Research – Receives S$6m Fund Infusion, Digital Assets Valued at S$60m
06 Jun 2022
PhillipCapital’s Equity Research – Digital Healthcare Catalyst Emerges
31 May 2022
Sustainability Report 2021
31 May 2022
Sustainability Report 2021
27 May 2022
InvestingNote – An Investor’s Analysis on Hyphens Pharma International Limited
27 May 2022
Corporate Presentation – DocMed
27 May 2022
The Business Times – Hyphens Pharma to sell 10% stake in digital healthtech unit to Metro for S$6m
27 May 2022
Hyphens Attracts S$6 million Investment in DocMed Technology to Grow Digital Healthtech
17 May 2022
SAC Capital’s Equity Research – Sterling 1Q22 Backed by Re-Opening Tailwind
13 May 2022
CGS-CIMB Singapore’s Equity Research – Building Up the Hype
12 May 2022
General Announcement: Quarterly Business Update for the First Quarter Ended 31 March 2022
06 May 2022
Announcement of Cessation: Resignation of Chief Financial Officer
27 Apr 2022
Results and Minutes of Annual General Meeting held on 27 April 2022
21 Apr 2022
Response to Substantial and Relevant Questions Received from Shareholders before Annual General Meeting
12 Apr 2022
Annual Report 2021
12 Apr 2022
Cash Dividend / Distribution: Mandatory
12 Apr 2022
Notice of Annual General Meeting
12 Apr 2022
Annual Reports and Related Documents
04 Apr 2022
KGI Securities’ Equity Research – Novem Acquisition to Boost Top and Bottom-Line Growth
16 Mar 2022
SAC Capital’s Equity Research – Moving in the Right Direction
02 Mar 2022
General Announcement: Results Briefing FY2021
02 Mar 2022
CGS-CIMB Singapore’s Equity Research – Quality Earnings to Come in FY22F
23 Feb 2022
Financial Statements and Related Announcement: Full Yearly Results
26 Jan 2022
Change in Corporate Information: Change of Address of Share Registrar
13 Jan 2022
The Straits Times – First HSA-registered e-pharmacy in Singapore launched
13 Jan 2022
General Announcement: Corporate Presentation
10 Jan 2022
Hyphens Pharma Officially Launches WellAway, Singapore’s First HSA-Registered e-Pharmacy
06 Jan 2022
CGS-CIMB Singapore’s Equity Research – On the Lookout for Growth
14 Dec 2021
Hyphens Pharma Has Inked Exclusive Licensing Deal of Ustekinumab Biosimilar
09 Dec 2021
Asset Acquisitions and Disposals: Striking-Off of Indirect Wholly-Owned Subsidiary, DAC Pharmalab Pte Ltd
03 Dec 2021
Change of Director’s Interest – Mr Tan Chwee Choon
03 Dec 2021
Change of Director’s Interest – Dr Tan Kia King
03 Dec 2021
Change of Director’s Interest – Mr Lim See Wah
03 Dec 2021
Change of Substantial Shareholder’s Interest – Inomed Holding Pte Ltd
03 Dec 2021
Asset Acquisitions and Disposals: Completion of the Proposed Acquisition of 100% of the Issued Share Capital in Novem Group
22 Nov 2021
PhillipCapital’s Equity Research – Speedbump in Vietnam
19 Nov 2021
General Announcement: Receipt of Approval In-Principle from SGX-ST for the Listing and Quotation for New Ordinary Shares
18 Nov 2021
SAC Capital’s Equity Research – Strategic Acquisition of Novem Group
16 Nov 2021
General Announcement: Acquisition of Novem & 3Q Business Update
12 Nov 2021
General Announcement: Quarterly Business Update for the Third Quarter and Nine Months Ended 30 September 2021
09 Nov 2021
Request for Lifting of Trading Halt
09 Nov 2021
Asset Acquisitions and Disposals: Entry into a Sale and Purchase Agreement Relating to the Proposed Acquisition
08 Nov 2021
Request for Trading Halt
10 Sep 2021
Change of Director’s Interest – Mr Lim See Wah
10 Sep 2021
Change of Substantial Shareholder’s Interest – Inomed Holding Pte Ltd
24 Aug 2021
SAC Capital’s Equity Research – Strongest 1H Recorded
18 Aug 2021
General Announcement: Results Briefing 1H2021
11 Aug 2021
Financial Statements and Related Announcement: Half Yearly Results
28 Jun 2021
KGI Securities’ Equity Research – A Fresh Start
17 May 2021
Sustainability Report 2020
17 May 2021
Sustainability Report 2020
12 May 2021
Change in Continuing Sponsor
12 May 2021
Quarterly Business Update: 1Q2021
28 Apr 2021
Results and Minutes of Annual General Meeting held on 28 April 2021
13 Apr 2021
Notice of Annual General Meeting
12 Apr 2021
Cash Dividend / Distribution: Mandatory
12 Apr 2021
Annual Reports and Related Documents
12 Apr 2021
Annual Report 2020
19 Mar 2021
Employee Stock Option / Share Scheme: Grant of Share Awards Pursuant to the Hyphens Share Plan
17 Mar 2021
SAC Capital’s Equity Research – Growing Regional Presence
05 Mar 2021
Change of Director’s Interest – Dr Tan Kia King
05 Mar 2021
Change of Director’s Interest – Mr Lim See Wah
05 Mar 2021
Change of Substantial Shareholder’s Interest – Inomed Holding Pte Ltd
05 Mar 2021
PhillipCapital’s Equity Research – Not to Be Written Off
03 Mar 2021
General Announcement: Results Briefing FY2020
25 Feb 2021
Financial Statements and Related Announcement: Full Yearly Results
18 Jan 2021
The Business Times – Hyphens Pharma to expand presence in South Korea through distribution agreement with JSPharma
18 Jan 2021
Hyphens Pharma Appoints Exclusive Distributor in South Korea for TDF Fairence® T-Complex
08 Jan 2021
Singapore Business Review – Hyphens Pharma subsidiary granted e-pharmacy license
07 Jan 2021
The Edge Singapore – Hyphens Pharma awarded e-pharmacy licence for WellAway Pharmacy
07 Jan 2021
Hyphens Pharma Awarded e-Pharmacy Licence for WellAway Pharmacy
19 Nov 2020
SAC Capital’s Equity Research – Q3 Setback, Longer-Term Growth is Priority
16 Nov 2020
General Announcement: Results Briefing 3Q2020
16 Nov 2020
KGI Securities’ Equity Research – Short Term Speed Bump in the Pursuit of Growth
16 Nov 2020
PhillipCapital’s Equity Research – Repositioning for Growth
12 Nov 2020
Hyphens Pharma Broadens Ceradan Brand’s Outreach to Mainland China
11 Nov 2020
Financial Statements and Related Announcement: Third Quarter Results
06 Nov 2020
KGI Securities’ Equity Research – Skin is the game
05 Nov 2020
General Announcement: Change in Composition of the Board of Directors and Board Committees
05 Nov 2020
Announcement of Appointment: Appointment of an Independent Non-Executive Director
03 Nov 2020
Hyphens Pharma Expands Ocean Health Distribution to Sri Lanka
29 Sep 2020
Lim & Tan Securities’ Equity Research – Special Report
11 Sep 2020
The Edge Singapore – Hyphens Pharma enjoys lift from broader product range and wider distribution channels
03 Sep 2020
Corporate Presentation
31 Aug 2020
SAC Capital’s Equity Research – Broadening Product Range and Footprints
24 Aug 2020
KGI Securities’ Equity Research – A Hair-Raising First Half
20 Aug 2020
PhillipCapital’s Equity Research – Shaking Off COVID-19 Woes with Expanded Portfolio
18 Aug 2020
Intangible Asset Portfolio Review
18 Aug 2020
General Announcement: Results Briefing 2Q2020
17 Aug 2020
Hyphens Pharma Inks Exclusive Partnership with SUTL to Distribute Ocean Health Products
13 Aug 2020
Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
03 Aug 2020
Corporate Presentation at ASEAN Regional Healthcare Conference by DBS
03 Aug 2020
Hyphens Pharma Expands Proprietary Brands Portfolio with Hair Loss Products
28 Jul 2020
Why Intangible Assets Matter
24 Jul 2020
Change of Director’s Interest – Mr Tan Chwee Choon
22 Jul 2020
Change of Director’s Interest – Mr Tan Chwee Choon
20 Jul 2020
PhillipCapital’s Equity Research – Building Channels to Establish Business Longevity
15 Jul 2020
Change of Director’s Interest – Mr Tan Chwee Choon
13 Jul 2020
Hyphens Pharma Receives UK Patent for Ceradan Advanced
24 Jun 2020
Change of Director’s Interest – Mr Tan Chwee Choon
12 Jun 2020
Results and Minutes of Annual General Meeting held on 12 June 2020
08 Jun 2020
Response to Queries from SIAS on Annual Report 2019
02 Jun 2020
Change of Director’s Interest – Mr Tan Chwee Choon
01 Jun 2020
Change of Director’s Interest – Mr Tan Chwee Choon
26 May 2020
Sustainability Report 2019
26 May 2020
Sustainability Report 2019
25 May 2020
The Business Times – Hyphens Pharma revs up digital push amid Covid-19
21 May 2020
SmallCapAsia – Hyphens Pharma: 5 things I like about the company
21 May 2020
Notice of Annual General Meeting
15 May 2020
RHB’s Equity Research – Numbers Improve During Pandemic; Stay BUY
14 May 2020
General Announcement: Results Briefing 1Q2020
11 May 2020
Cash Dividend / Distribution: Mandatory
11 May 2020
General Announcement: Update on FY2019 Proposed Final Dividend of S$0.01 per Share
11 May 2020
Financial Statements and Related Announcement: First Quarter Results
28 Apr 2020
Response to Query Regarding Trading Activity
27 Apr 2020
General Announcement – Voluntary Continuation of Quarterly Reporting and Deferment of Half-Yearly Reporting
17 Apr 2020
General Announcement: Change in Composition of the Board of Directors and Board Committees
17 Apr 2020
Announcement of Cessation: Resignation of an Independent Director
09 Apr 2020
General Announcement: Business Continuity During Covid-19 Pandemic
08 Apr 2020
Waiver: Extension of Time to Hold Annual General Meeting for Financial Year Ended 31 December 2019
08 Apr 2020
Annual Report 2019
08 Apr 2020
Annual Reports and Related Documents
04 Mar 2020
RHB’s Equity Research – Near-Term Outlook Uncertain Due to COVID-19; BUY Maintained
03 Mar 2020
General Announcement: Hyphens Results Briefing FY2019
26 Feb 2020
Financial Statements and Related Announcement: Full Yearly Results
06 Feb 2020
General Announcement: TDF Fairence T-Complex has efficacy tests affirmed in Journal of Cosmetic Dermatology
04 Feb 2020
IPOS and SGX Launch Pilot Programme to Help Companies Identify and Communicate Intangible Assets Information
17 Dec 2019
General Announcement: Hyphens Pharma inks Research Collaboration Agreement with the Institute of Chemical and Engineering Sciences
08 Dec 2019
The Straits Times – Aiming to be Asia’s No. 1 skin-health firm
22 Nov 2019
SAC Capital’s Equity Research – 3Q2019 Results Review
20 Nov 2019
RHB’s Equity Research – Banking on Ceradan Products; Keep Buy
19 Nov 2019
General Announcement: Hyphens Results Briefing 3Q2019
14 Nov 2019
Financial Statements and Related Announcement: Third Quarter Results
08 Nov 2019
SAC Capital’s Equity Research – Healthy Prospects in ASEAN
05 Nov 2019
Announcement of Cessation: Resignation of General Manager
22 Oct 2019
PhillipCapital’s Equity Research – Leveraging on Trust with Doctors for Profitability
30 Aug 2019
Announcement of Appointment: Appointment of Chief Operating Officer
20 Aug 2019
RHB’s Equity Research – Ceradan Leading The Pack; Keep Buy
19 Aug 2019
General Announcement: Hyphens Results Briefing 2Q2019
13 Aug 2019
Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
29 Jul 2019
Announcement of Appointment: Appointment of an Independent Non-Executive Director
22 Jul 2019
General Announcement: Ocean Health revamped, unveils new and refreshed look
10 Jul 2019
General Announcement: Hyphens Pharma launches New Ceradan Advanced
03 Jul 2019
RHB’s Equity Research – Hyphens Pharma: Undervalued and Under-Covered; Initiate BUY
17 Jun 2019
General Announcement: Hyphens Pharma first to introduce bioabsorbable metallic implants to Vietnam
30 May 2019
General Announcement: Hyphens Pharma Signs Exclusive Distribution Agreement with Lundbeck for Vietnam
17 May 2019
General Announcement: Corporate Presentations – Hyphens Results Briefing 1Q2019
17 May 2019
General Announcement: Corporate Presentations – Hyphens Presentation Deck
17 May 2019
General Announcement: Corporate Presentations
16 May 2019
Investor-One – Hyphens Pharma: A scalable business that rides on regional megatrends
16 May 2019
Investor-One – Hyphens Pharma’s CEO Lim See Wah tells us about Hyphens’ presence and growth prospects in the region [Video]
15 May 2019
Employee Stock Option / Share Scheme: Grant of Share Awards Pursuant to the Hyphens Share Plan
13 May 2019
Financial Statements and Related Announcement: First Quarter Results
10 May 2019
RHB’s 20 Jewels 2019 Edition: Investor-One’s Analysis Of 5 Catalist Stocks
09 May 2019
联合早报 – 兴业研究:估值极低科技与制造业股有望后势看涨
07 May 2019
RHB’s 2019 Top Singapore Small Cap Companies (9th Edition) [PDF]
29 Apr 2019
The Business Times – Hyphens flies Asian flag in pharma industry
26 Apr 2019
Annual General Meeting: Results and Presentation Slides
26 Apr 2019
SGX – Hyphens Flies Asian Flag in Pharma Industry
22 Apr 2019
联合早报 – 凯帆药剂新总部开幕 许宝琨:本地公司 须持续创新建立竞争优势
18 Apr 2019
Asset Acquisitions and Disposals: Striking-Off Of Indirect Wholly-Owned Subsidiary – Ocean Healthcare (M) Sdn. Bhd.
10 Apr 2019
Notice of Annual General Meeting
10 Apr 2019
Annual Reports and Related Documents
10 Apr 2019
Cash Dividend/Distribution: Mandatory
28 Mar 2019
SGX – 10 in 10 with Hyphens Pharma International [PDF]
22 Mar 2019
The Business Times – Hyphens inks MOU with A*Star’s A*ccelerate
22 Mar 2019
Berita Mediacorp – Produk-produk baru bagi masalah kulit mungkin diperkenalkan seawal tahun depan
22 Mar 2019
The Straits Times – Innovate for global competitive edge, says Koh Poh Koon
22 Mar 2019
The New Paper – Innovation key to help companies expand: Koh Poh Koon
21 Mar 2019
Channel News Asia – New products in the works for common skin problems
21 Mar 2019
General Announcement: Hyphens Pharma Officially Opens Corporate Headquarters and Integrated Facility
06 Mar 2019
General Announcement: Hyphens Results Briefing 4Q2018 / FY2018
28 Feb 2019
Financial Statements and Related Announcement: Full Yearly Results
18 Feb 2019
General Announcement: Hyphens Pharma appoints Industry Veteran to head Dermatology Business Unit
31 Dec 2018
Annual Report 2018
05 Dec 2018
General Announcement: Entry into Memorandum of Understanding with Doctor Anywhere
22 Nov 2018
Interview with Lianhe Zaobao
13 Nov 2018
Financial Statements and Related Announcement: Third Quarter Results
29 Sep 2018
Change in Corporate Information: Change of Registered Office
29 Aug 2018
General Announcement: Corporate Presentation at INVEST Fair 2018
10 Aug 2018
Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
23 May 2018
General Announcement: Tenancy Agreement with RBC Investor Services Trust Singapore Limited
18 May 2018
General Announcement: Balloting Result under Public Offer of Related Persons
18 May 2018
Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Executive Chairman and CEO – Mr Lim See Wah
18 May 2018
Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Executive Director – Mr Tan Chwee Choon
18 May 2018
Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Non-Executive Director – Dr Tan Kia King
18 May 2018
Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s): Disclosure of interest by substantial shareholder – Inomed Holding Pte Ltd
18 May 2018
General Announcement: Hyphens Pharma International Makes Strong Listing Debut on the Catalist Board of the SGX-ST
17 May 2018
Equity – Listing Confirmation: Admission of 300,000,000 ordinary shares to the Official List of SGX-Catalist
17 May 2018
General Announcement: Balloting Results
11 May 2018
IPO Offer Document
25 Mar 2024
Change of Director’s Interest – Chan Kiat
22 Mar 2024
Change of Director’s Interest – Dr Tan Kia King
13 Mar 2024
CGS International Equity Research: FY2023 Positive on Expanding Portfolio
12 Mar 2024
General Announcement: Hyphens Pharma licenses Wynzora® Cream for ASEAN countries from MC2 Therapeutics
06 Mar 2024
FY2023 Full-Year Financial Results Briefing
29 Feb 2024
General Announcement: Hyphens Pharma’s Ceradan range of products to enter major Middle East markets
27 Feb 2024
Financial Statements and Related Announcement: Full Yearly Results
06 Feb 2024
General Announcement: Hyphens Pharma partners 7-Eleven to offer Ocean Health® supplements at selected convenience stores in Singapore
08 Dec 2023
Employee Stock Option/Share Scheme: Grant of Share Awards Pursuant to the Hyphens Share Plan
27 Nov 2023
CGS-CIMB Equity Research: Dented Margins in 3Q23
20 Nov 2023
SAC Equity’s Capital Research – 3Q23 Business Update
09 Nov 2023
The Edge Singapore: Hyphens Pharma’s high returns to shareholders fuelled by a post-pandemic boom, accretive acquisition
09 Nov 2023
General Announcement: Quarterly Business Update for the Third Quarter and Nine Months Ended 30 September 2023
08 Nov 2023
Asset Acquisitions and Disposals: Completion Of Proposed Acquisition Of Tranche 1 Sale Shares Of 23% In Ardence Pharma Sdn Bhd
20 Oct 2023
SAC Equity’s Capital Research – Pursuing Growth Through Full Acquisition of Ardence Pharma
19 Oct 2023
General Announcement : Analyst Briefing – Acquisition of Ardence Malaysia
17 Oct 2023
Asset Acquisitions and Disposals: Proposed Acquisition Of 58% Of The Share Capital In Ardence Pharma Sdn Bhd Over 3 Tranches
17 Oct 2023
The Edge Singapore: Hyphens Pharma to acquire remaining 58% of shares in Ardence Pharma, making it a wholly-owned subsidiary
30 Aug 2023
General Announcement: Nabota® successfully registered in Malaysia
22 Aug 2023
PhillipCapital’s Equity Research – Year of Investment and Challenges
18 Aug 2023
Investor-One: What You Need to Know About Hyphens Pharma’s 1H2023 Financial Results
18 Aug 2023
CGS-CIMB Equity Research: A Game of Catch-Up for 2H23F
17 Aug 2023
SAC Equity’s Capital Research – Navigating Challenges Amidst Ongoing Improvements
17 Aug 2023
General Announcement: Results Briefing 1H 2023
11 Aug 2023
Financial Statements and Related Announcement: Half Yearly Results
11 Aug 2023
Cash Dividend / Distribution: Mandatory
19 Jul 2023
Change of Substantial Shareholder’s Interest – Inomed Holding Pte Ltd
19 Jul 2023
Change of Director’s Interest – Mr Lim See Wah
19 Jul 2023
Change of Director’s Interest – Dr Tan Kia King
19 Jul 2023
Cessation of Substantial Shareholder’s Interest – Mr Tan Chwee Choon
05 Jun 2023
(Board Approval) Hyphens Pharma International – Appointment of CFO
25 May 2023
SAC Capital’s Equity Research – Beyond the Shores
24 May 2023
General Announcement: Minutes of Annual General Meeting and Extraordinary General Meeting held on 26 April 2023
17 May 2023
General Announcement: Hyphens Pharma to develop and commercialise Byfavo procedural sedation drug in Singapore
16 May 2023
CGS-CIMB Singapore’s Equity Research – Hit by Supply Chain Disruptions
11 May 2023
General Announcement: Business Update and Results Briefing for the First Quarter Ended 31 March 2023
28 Apr 2023
Employee Stock Option / Share Scheme: Allotment and Issuance of 422,000 New Ordinary Shares Under the Hyphens Performance Share Plan
26 Apr 2023
Results of Extraordinary General Meeting held on 26 April 2023
26 Apr 2023
Results of Annual General Meeting held on 26 April 2023
21 Apr 2023
Response to Queries from SIAS on Annual Report 2022
21 Apr 2023
Response to Substantial and Relevant Questions Received from Shareholders before Annual General Meeting
13 Apr 2023
CGS-CIMB Singapore’s Equity Research – DocMed Undertakes Vietnam Digital Venture
10 Apr 2023
Announcement of Cessation: Cessation of an Executive Director
10 Apr 2023
Cash Dividend / Distribution: Mandatory
10 Apr 2023
Notice of Extraordinary General Meeting
10 Apr 2023
Notice of Annual General Meeting
10 Apr 2023
Annual Report 2022
10 Apr 2023
Annual Reports and Related Documents
09 Mar 2023
PhillipCapital’s Equity Research – Assembling Multiple Growth Engines
07 Mar 2023
CGS-CIMB Singapore’s Equity Research – FY23F Sets Stage for More Investments
06 Mar 2023
General Announcement: Results Briefing FY2022
28 Feb 2023
Financial Statements and Related Announcement: Full Yearly Results
10 Feb 2023
General Announcement: Nabota® Successfully Registered in Singapore
30 Jan 2023
The Business Times – Hyphens Pharma to expand footprint in Southeast Asia: CEO
21 Dec 2022
General Announcement: Hyphens Pharma licenses Winlevi® for all 10 ASEAN countries from Cosmo Pharmaceuticals
05 Dec 2022
General Announcement: Hyphens Pharma’s Meradan® Cream Launches in Indonesia
24 Nov 2022
CGS-CIMB Singapore’s Equity Research – Steadfast in Executing its Business Strategy
09 Nov 2022
General Announcement: Quarterly Business Update for the Third Quarter and Nine Months Ended 30 September 2022
15 Sep 2022
General Announcement: Hyphens Pharma’s TDF Blu Voile Sunscreen
28 Aug 2022
PhillipCapital’s Equity Research – Franchise Expands with Acquisitions
25 Aug 2022
联合早报 – 善用传统学养与数码能力首创综合式医疗科技平台
18 Aug 2022
SAC Capital’s Equity Research – Growth from Organic and Acquisition
17 Aug 2022
CGS-CIMB Singapore’s Equity Research – Positioning for Next Phase of Growth
17 Aug 2022
General Announcement: Results Briefing 1H2022
11 Aug 2022
Financial Statements and Related Announcement: Half Yearly Results
06 Jun 2022
General Announcement: Completion of Investment in DocMed Technology
06 Jun 2022
SAC Capital’s Equity Research – Receives S$6m Fund Infusion, Digital Assets Valued at S$60m
06 Jun 2022
PhillipCapital’s Equity Research – Digital Healthcare Catalyst Emerges
31 May 2022
Sustainability Report 2021
31 May 2022
Sustainability Report 2021
27 May 2022
InvestingNote – An Investor’s Analysis on Hyphens Pharma International Limited
27 May 2022
Corporate Presentation – DocMed
27 May 2022
The Business Times – Hyphens Pharma to sell 10% stake in digital healthtech unit to Metro for S$6m
27 May 2022
Hyphens Attracts S$6 million Investment in DocMed Technology to Grow Digital Healthtech
17 May 2022
SAC Capital’s Equity Research – Sterling 1Q22 Backed by Re-Opening Tailwind
13 May 2022
CGS-CIMB Singapore’s Equity Research – Building Up the Hype
12 May 2022
General Announcement: Quarterly Business Update for the First Quarter Ended 31 March 2022
06 May 2022
Announcement of Cessation: Resignation of Chief Financial Officer
27 Apr 2022
Results and Minutes of Annual General Meeting held on 27 April 2022
21 Apr 2022
Response to Substantial and Relevant Questions Received from Shareholders before Annual General Meeting
12 Apr 2022
Annual Report 2021
12 Apr 2022
Cash Dividend / Distribution: Mandatory
12 Apr 2022
Notice of Annual General Meeting
12 Apr 2022
Annual Reports and Related Documents
04 Apr 2022
KGI Securities’ Equity Research – Novem Acquisition to Boost Top and Bottom-Line Growth
16 Mar 2022
SAC Capital’s Equity Research – Moving in the Right Direction
02 Mar 2022
General Announcement: Results Briefing FY2021
02 Mar 2022
CGS-CIMB Singapore’s Equity Research – Quality Earnings to Come in FY22F
23 Feb 2022
Financial Statements and Related Announcement: Full Yearly Results
26 Jan 2022
Change in Corporate Information: Change of Address of Share Registrar
13 Jan 2022
The Straits Times – First HSA-registered e-pharmacy in Singapore launched
13 Jan 2022
General Announcement: Corporate Presentation
10 Jan 2022
Hyphens Pharma Officially Launches WellAway, Singapore’s First HSA-Registered e-Pharmacy
06 Jan 2022
CGS-CIMB Singapore’s Equity Research – On the Lookout for Growth
14 Dec 2021
Hyphens Pharma Has Inked Exclusive Licensing Deal of Ustekinumab Biosimilar
09 Dec 2021
Asset Acquisitions and Disposals: Striking-Off of Indirect Wholly-Owned Subsidiary, DAC Pharmalab Pte Ltd
03 Dec 2021
Change of Director’s Interest – Mr Tan Chwee Choon
03 Dec 2021
Change of Director’s Interest – Dr Tan Kia King
03 Dec 2021
Change of Director’s Interest – Mr Lim See Wah
03 Dec 2021
Change of Substantial Shareholder’s Interest – Inomed Holding Pte Ltd
03 Dec 2021
Asset Acquisitions and Disposals: Completion of the Proposed Acquisition of 100% of the Issued Share Capital in Novem Group
22 Nov 2021
PhillipCapital’s Equity Research – Speedbump in Vietnam
19 Nov 2021
General Announcement: Receipt of Approval In-Principle from SGX-ST for the Listing and Quotation for New Ordinary Shares
18 Nov 2021
SAC Capital’s Equity Research – Strategic Acquisition of Novem Group
16 Nov 2021
General Announcement: Acquisition of Novem & 3Q Business Update
12 Nov 2021
General Announcement: Quarterly Business Update for the Third Quarter and Nine Months Ended 30 September 2021
09 Nov 2021
Request for Lifting of Trading Halt
09 Nov 2021
Asset Acquisitions and Disposals: Entry into a Sale and Purchase Agreement Relating to the Proposed Acquisition
08 Nov 2021
Request for Trading Halt
10 Sep 2021
Change of Director’s Interest – Mr Lim See Wah
10 Sep 2021
Change of Substantial Shareholder’s Interest – Inomed Holding Pte Ltd
24 Aug 2021
SAC Capital’s Equity Research – Strongest 1H Recorded
18 Aug 2021
General Announcement: Results Briefing 1H2021
11 Aug 2021
Financial Statements and Related Announcement: Half Yearly Results
28 Jun 2021
KGI Securities’ Equity Research – A Fresh Start
17 May 2021
Sustainability Report 2020
17 May 2021
Sustainability Report 2020
12 May 2021
Change in Continuing Sponsor
12 May 2021
Quarterly Business Update: 1Q2021
28 Apr 2021
Results and Minutes of Annual General Meeting held on 28 April 2021
13 Apr 2021
Notice of Annual General Meeting
12 Apr 2021
Cash Dividend / Distribution: Mandatory
12 Apr 2021
Annual Reports and Related Documents
12 Apr 2021
Annual Report 2020
19 Mar 2021
Employee Stock Option / Share Scheme: Grant of Share Awards Pursuant to the Hyphens Share Plan
17 Mar 2021
SAC Capital’s Equity Research – Growing Regional Presence
05 Mar 2021
Change of Director’s Interest – Dr Tan Kia King
05 Mar 2021
Change of Director’s Interest – Mr Lim See Wah
05 Mar 2021
Change of Substantial Shareholder’s Interest – Inomed Holding Pte Ltd
05 Mar 2021
PhillipCapital’s Equity Research – Not to Be Written Off
03 Mar 2021
General Announcement: Results Briefing FY2020
25 Feb 2021
Financial Statements and Related Announcement: Full Yearly Results
18 Jan 2021
The Business Times – Hyphens Pharma to expand presence in South Korea through distribution agreement with JSPharma
18 Jan 2021
Hyphens Pharma Appoints Exclusive Distributor in South Korea for TDF Fairence® T-Complex
08 Jan 2021
Singapore Business Review – Hyphens Pharma subsidiary granted e-pharmacy license
07 Jan 2021
The Edge Singapore – Hyphens Pharma awarded e-pharmacy licence for WellAway Pharmacy
07 Jan 2021
Hyphens Pharma Awarded e-Pharmacy Licence for WellAway Pharmacy
19 Nov 2020
SAC Capital’s Equity Research – Q3 Setback, Longer-Term Growth is Priority
16 Nov 2020
General Announcement: Results Briefing 3Q2020
16 Nov 2020
KGI Securities’ Equity Research – Short Term Speed Bump in the Pursuit of Growth
16 Nov 2020
PhillipCapital’s Equity Research – Repositioning for Growth
12 Nov 2020
Hyphens Pharma Broadens Ceradan Brand’s Outreach to Mainland China
11 Nov 2020
Financial Statements and Related Announcement: Third Quarter Results
06 Nov 2020
KGI Securities’ Equity Research – Skin is the game
05 Nov 2020
General Announcement: Change in Composition of the Board of Directors and Board Committees
05 Nov 2020
Announcement of Appointment: Appointment of an Independent Non-Executive Director
03 Nov 2020
Hyphens Pharma Expands Ocean Health Distribution to Sri Lanka
29 Sep 2020
Lim & Tan Securities’ Equity Research – Special Report
11 Sep 2020
The Edge Singapore – Hyphens Pharma enjoys lift from broader product range and wider distribution channels
03 Sep 2020
Corporate Presentation
31 Aug 2020
SAC Capital’s Equity Research – Broadening Product Range and Footprints
24 Aug 2020
KGI Securities’ Equity Research – A Hair-Raising First Half
20 Aug 2020
PhillipCapital’s Equity Research – Shaking Off COVID-19 Woes with Expanded Portfolio
18 Aug 2020
Intangible Asset Portfolio Review
18 Aug 2020
General Announcement: Results Briefing 2Q2020
17 Aug 2020
Hyphens Pharma Inks Exclusive Partnership with SUTL to Distribute Ocean Health Products
13 Aug 2020
Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
03 Aug 2020
Corporate Presentation at ASEAN Regional Healthcare Conference by DBS
03 Aug 2020
Hyphens Pharma Expands Proprietary Brands Portfolio with Hair Loss Products
28 Jul 2020
Why Intangible Assets Matter
24 Jul 2020
Change of Director’s Interest – Mr Tan Chwee Choon
22 Jul 2020
Change of Director’s Interest – Mr Tan Chwee Choon
20 Jul 2020
PhillipCapital’s Equity Research – Building Channels to Establish Business Longevity
15 Jul 2020
Change of Director’s Interest – Mr Tan Chwee Choon
13 Jul 2020
Hyphens Pharma Receives UK Patent for Ceradan Advanced
24 Jun 2020
Change of Director’s Interest – Mr Tan Chwee Choon
12 Jun 2020
Results and Minutes of Annual General Meeting held on 12 June 2020
08 Jun 2020
Response to Queries from SIAS on Annual Report 2019
02 Jun 2020
Change of Director’s Interest – Mr Tan Chwee Choon
01 Jun 2020
Change of Director’s Interest – Mr Tan Chwee Choon
26 May 2020
Sustainability Report 2019
26 May 2020
Sustainability Report 2019
25 May 2020
The Business Times – Hyphens Pharma revs up digital push amid Covid-19
21 May 2020
SmallCapAsia – Hyphens Pharma: 5 things I like about the company
21 May 2020
Notice of Annual General Meeting
15 May 2020
RHB’s Equity Research – Numbers Improve During Pandemic; Stay BUY
14 May 2020
General Announcement: Results Briefing 1Q2020
11 May 2020
Cash Dividend / Distribution: Mandatory
11 May 2020
General Announcement: Update on FY2019 Proposed Final Dividend of S$0.01 per Share
11 May 2020
Financial Statements and Related Announcement: First Quarter Results
28 Apr 2020
Response to Query Regarding Trading Activity
27 Apr 2020
General Announcement – Voluntary Continuation of Quarterly Reporting and Deferment of Half-Yearly Reporting
17 Apr 2020
General Announcement: Change in Composition of the Board of Directors and Board Committees
17 Apr 2020
Announcement of Cessation: Resignation of an Independent Director
09 Apr 2020
General Announcement: Business Continuity During Covid-19 Pandemic
08 Apr 2020
Waiver: Extension of Time to Hold Annual General Meeting for Financial Year Ended 31 December 2019
08 Apr 2020
Annual Report 2019
08 Apr 2020
Annual Reports and Related Documents
04 Mar 2020
RHB’s Equity Research – Near-Term Outlook Uncertain Due to COVID-19; BUY Maintained
03 Mar 2020
General Announcement: Hyphens Results Briefing FY2019
26 Feb 2020
Financial Statements and Related Announcement: Full Yearly Results
06 Feb 2020
General Announcement: TDF Fairence T-Complex has efficacy tests affirmed in Journal of Cosmetic Dermatology
04 Feb 2020
IPOS and SGX Launch Pilot Programme to Help Companies Identify and Communicate Intangible Assets Information
17 Dec 2019
General Announcement: Hyphens Pharma inks Research Collaboration Agreement with the Institute of Chemical and Engineering Sciences
08 Dec 2019
The Straits Times – Aiming to be Asia’s No. 1 skin-health firm
22 Nov 2019
SAC Capital’s Equity Research – 3Q2019 Results Review
20 Nov 2019
RHB’s Equity Research – Banking on Ceradan Products; Keep Buy
19 Nov 2019
General Announcement: Hyphens Results Briefing 3Q2019
14 Nov 2019
Financial Statements and Related Announcement: Third Quarter Results
08 Nov 2019
SAC Capital’s Equity Research – Healthy Prospects in ASEAN
05 Nov 2019
Announcement of Cessation: Resignation of General Manager
22 Oct 2019
PhillipCapital’s Equity Research – Leveraging on Trust with Doctors for Profitability
30 Aug 2019
Announcement of Appointment: Appointment of Chief Operating Officer
20 Aug 2019
RHB’s Equity Research – Ceradan Leading The Pack; Keep Buy
19 Aug 2019
General Announcement: Hyphens Results Briefing 2Q2019
13 Aug 2019
Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
29 Jul 2019
Announcement of Appointment: Appointment of an Independent Non-Executive Director
22 Jul 2019
General Announcement: Ocean Health revamped, unveils new and refreshed look
10 Jul 2019
General Announcement: Hyphens Pharma launches New Ceradan Advanced
03 Jul 2019
RHB’s Equity Research – Hyphens Pharma: Undervalued and Under-Covered; Initiate BUY
17 Jun 2019
General Announcement: Hyphens Pharma first to introduce bioabsorbable metallic implants to Vietnam
30 May 2019
General Announcement: Hyphens Pharma Signs Exclusive Distribution Agreement with Lundbeck for Vietnam
17 May 2019
General Announcement: Corporate Presentations – Hyphens Results Briefing 1Q2019
17 May 2019
General Announcement: Corporate Presentations – Hyphens Presentation Deck
17 May 2019
General Announcement: Corporate Presentations
16 May 2019
Investor-One – Hyphens Pharma: A scalable business that rides on regional megatrends
16 May 2019
Investor-One – Hyphens Pharma’s CEO Lim See Wah tells us about Hyphens’ presence and growth prospects in the region [Video]
15 May 2019
Employee Stock Option / Share Scheme: Grant of Share Awards Pursuant to the Hyphens Share Plan
13 May 2019
Financial Statements and Related Announcement: First Quarter Results
10 May 2019
RHB’s 20 Jewels 2019 Edition: Investor-One’s Analysis Of 5 Catalist Stocks
09 May 2019
联合早报 – 兴业研究:估值极低科技与制造业股有望后势看涨
07 May 2019
RHB’s 2019 Top Singapore Small Cap Companies (9th Edition) [PDF]
29 Apr 2019
The Business Times – Hyphens flies Asian flag in pharma industry
26 Apr 2019
Annual General Meeting: Results and Presentation Slides
26 Apr 2019
SGX – Hyphens Flies Asian Flag in Pharma Industry
22 Apr 2019
联合早报 – 凯帆药剂新总部开幕 许宝琨:本地公司 须持续创新建立竞争优势
18 Apr 2019
Asset Acquisitions and Disposals: Striking-Off Of Indirect Wholly-Owned Subsidiary – Ocean Healthcare (M) Sdn. Bhd.
10 Apr 2019
Notice of Annual General Meeting
10 Apr 2019
Annual Reports and Related Documents
10 Apr 2019
Cash Dividend/Distribution: Mandatory
28 Mar 2019
SGX – 10 in 10 with Hyphens Pharma International [PDF]
22 Mar 2019
The Business Times – Hyphens inks MOU with A*Star’s A*ccelerate
22 Mar 2019
Berita Mediacorp – Produk-produk baru bagi masalah kulit mungkin diperkenalkan seawal tahun depan
22 Mar 2019
The Straits Times – Innovate for global competitive edge, says Koh Poh Koon
22 Mar 2019
The New Paper – Innovation key to help companies expand: Koh Poh Koon
21 Mar 2019
Channel News Asia – New products in the works for common skin problems
21 Mar 2019
General Announcement: Hyphens Pharma Officially Opens Corporate Headquarters and Integrated Facility
06 Mar 2019
General Announcement: Hyphens Results Briefing 4Q2018 / FY2018
28 Feb 2019
Financial Statements and Related Announcement: Full Yearly Results
18 Feb 2019
General Announcement: Hyphens Pharma appoints Industry Veteran to head Dermatology Business Unit
31 Dec 2018
Annual Report 2018
05 Dec 2018
General Announcement: Entry into Memorandum of Understanding with Doctor Anywhere
22 Nov 2018
Interview with Lianhe Zaobao
13 Nov 2018
Financial Statements and Related Announcement: Third Quarter Results
29 Sep 2018
Change in Corporate Information: Change of Registered Office
29 Aug 2018
General Announcement: Corporate Presentation at INVEST Fair 2018
10 Aug 2018
Financial Statements and Related Announcement: Second Quarter and/or Half Yearly Results
23 May 2018
General Announcement: Tenancy Agreement with RBC Investor Services Trust Singapore Limited
18 May 2018
General Announcement: Balloting Result under Public Offer of Related Persons
18 May 2018
Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Executive Chairman and CEO – Mr Lim See Wah
18 May 2018
Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Executive Director – Mr Tan Chwee Choon
18 May 2018
Disclosure of Interest/Changes in Interest of Director/Chief Executive Officer: Disclosure of interest by Non-Executive Director – Dr Tan Kia King
18 May 2018
Disclosure of Interest/Changes in Interest of Substantial Shareholder(s)/Unitholder(s): Disclosure of interest by substantial shareholder – Inomed Holding Pte Ltd
18 May 2018
General Announcement: Hyphens Pharma International Makes Strong Listing Debut on the Catalist Board of the SGX-ST
17 May 2018
Equity – Listing Confirmation: Admission of 300,000,000 ordinary shares to the Official List of SGX-Catalist
17 May 2018
General Announcement: Balloting Results
11 May 2018
IPO Offer Document